key: cord-0728392-b93pvl44
authors: De Nicola, Beatrice; Lech, Christopher J.; Heddi, Brahim; Regmi, Sagar; Frasson, Ilaria; Perrone, Rosalba; Richter, Sara N.; Phan, Anh Tuân
title: Structure and possible function of a G-quadruplex in the long terminal repeat of the proviral HIV-1 genome
date: 2016-07-27
journal: Nucleic Acids Res
DOI: 10.1093/nar/gkw432
sha: a8119ed9e9815a775ecff9c603542fe9ff7ae725
doc_id: 728392
cord_uid: b93pvl44

The long terminal repeat (LTR) of the proviral human immunodeficiency virus (HIV)-1 genome is integral to virus transcription and host cell infection. The guanine-rich U3 region within the LTR promoter, previously shown to form G-quadruplex structures, represents an attractive target to inhibit HIV transcription and replication. In this work, we report the structure of a biologically relevant G-quadruplex within the LTR promoter region of HIV-1. The guanine-rich sequence designated LTR-IV forms a well-defined structure in physiological cationic solution. The nuclear magnetic resonance (NMR) structure of this sequence reveals a parallel-stranded G-quadruplex containing a single-nucleotide thymine bulge, which participates in a conserved stacking interaction with a neighboring single-nucleotide adenine loop. Transcription analysis in a HIV-1 replication competent cell indicates that the LTR-IV region may act as a modulator of G-quadruplex formation in the LTR promoter. Consequently, the LTR-IV G-quadruplex structure presented within this work could represent a valuable target for the design of HIV therapeutics.

G-quadruplexes are nucleic acid secondary structures that may form in G-rich sequences under physiological conditions (1) (2) (3) . In contrast to duplex DNA formed by Watson-Crick base-pairing, the building blocks of G-quadruplexes are stacked guanine tetrads (G-tetrads) assembled by Hoogsteen-type base-pairing. The presence of coordinating cations is important to G-quadruplex formation and stability (4) (5) (6) . G-quadruplex structures are highly polymorphic, both in terms of strand stoichiometry (forming inter-and intramolecular structures) and strand orientation/topology (7, 8) . G-quadruplex-forming motifs have been found in telomeres, G-rich micro-and mini-satellites and near oncogene promoters (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Human G-quadruplex DNA motifs have been reported to be associated with recombination prone regions (18) and to show mutational patterns that preserved the potential to form G-quadruplex DNA structures (14) . Expansion of G-quadruplex-forming motifs has been associated with relevant human neurological disorders (19) (20) (21) (22) (23) (24) (25) . The identification of G-quadruplex binding proteins (26, 27) and their visualization in cells with antibodybased technology (28, 29) have also provided convincing evidence of the existence of G-quadruplexes in vivo.

Recently, the presence of G-quadruplexes in viruses and their involvement in viral key steps have also been reported (30) . G-quadruplexes have been implicated in pathogenic mechanisms of the Epstein-Barr virus (31, 32) , SARS coronavirus (33) , herpes simplex virus 1 (34) and the human papillomavirus (35) . We and other groups have identified functionally significant G-quadruplexes in the Nef coding region (36) and the unique long terminal repeat (LTR) promoter (37) (38) (39) of the human immunodeficiency virus (HIV), the etiologic agent of the acquired immune deficiency syndrome (AIDS), a major worldwide epidemic.

HIV establishes a persistent infection in human hosts, with the depletion of CD4+ lymphocytes, the major target cells of viral infection in vivo, eventually resulting in defective cellular immunity, and thus leading to full-blown AIDS. The Joint United Nations Programme on HIV/AIDS (UN-AIDS) estimates that there were 35.3 million people living with HIV at the end of 2012 compared with 26.2 million in 1999 -a 35% increase. Although important progress has been achieved in preventing new HIV infections and prolonging HIV patients' life with antiretroviral therapy, the infection cannot be eradicated and therefore AIDS-related illnesses are projected to continue as a significant worldwide cause of premature mortality in the coming decades if a decisive cure is not found (40) .

HIV is composed of two copies of positive singlestranded RNA that codes for the nine virus genes. The genomic RNA is reverse transcribed into a linear double- Figure 1 . Sequence of the G-rich region embedded in the U3 moiety of the LTR promoter in the proviral HIV-1 genome. The LTR-IV sequence is the focus of this work. The LTR-III and LTR-II regions are also shown. stranded DNA molecule that is next integrated into the human chromosome by the viral enzyme integrase. The stably integrated HIV-1 provirus, a 10 kb-long DNA molecule, serves as a template for the transcription of viral messengers and genomic RNA by the cellular Pol II polymerase (41) . Viral transcription is triggered by the interaction of cellular transcription factors with the U3 region of the LTR promoter ( Figure 1 ) (42) . The LTR promoter contains multiple G-rich sequences that have been shown to adopt Gquadruplex structures. The formation of G-quadruplexes in the LTR results in decreased viral transcription (37) , with an effect that is enhanced by the presence of the cellular protein nucleolin (43) and G-quadruplex ligands (44) .

Interestingly, within the G-rich region of the LTR promoter one of the LTR G-quadruplexes, termed LTR-IV, does not readily form in physiological ionic conditions. However, LTR-IV can be induced by a G-quadruplex stabilizing ligand (37) , making it a good G-quadruplex targets for antiviral therapy.

Several G-quadruplex ligands have been developed against cellular G-quadruplexes implicated in tumor pathogenesis; at least two molecules have also been tested and proved effective as antiviral agents against HIV (36, 44) . Recently, a few compounds selective for HIV-1 LTR Gquadruplexes have also been reported (45) . These studies have shown the potential of developing antiviral molecules with a G-quadruplex-mediated mechanism of action. To increase the selectivity of G-quadruplex binding ligands toward a viral target over other G-quadruplexes that may form within the cell, the high-resolution structure of the target G-quadruplexes will allow the rational design and virtual screening of molecules with selective binding. Considering the value of such target elucidation, we report on the nuclear magnetic resonance (NMR) solution structure of a G-quadruplex formed by the 22-nt G-rich LTR-IV sequence (5 -CTG 3 CG 3 ACTG 4 AGTG 2 T-3 ) from the promoter region of the HIV-1 LTR.

Oligonucleotides used in the Taq polymerase stop assay and in the construction/mutagenesis of the plasmids for the luciferase reporter assay were purchased from Sigma Aldrich (Milan, Italy). All other DNA oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA, USA) or chemically synthesized on an ABI 394 DNA/RNA synthesizer. Synthesized oligonucleotides were purified and dialyzed successively against 20 mM KCl solution and water before being lyophilized. DNA concentration was expressed in strand molarity using a nearest-neighbor approximation for the absorption coefficients of the unfolded species (46) .

The molecular size of G-quadruplexes was visualized by non-denaturing polyacrylamide gel electrophoresis (PAGE). Samples were incubated in 10 mM potassium phosphate buffer (pH 7) before loaded on 20% polyacrylamide gels with 40% (v/v) sucrose added before loading. Gels were run with 10 mM potassium phosphate buffer (pH 7) at room temperature for 90 min at 120 volts. DNA migration was imaged using UV-shadowing. For Taq polymerase stop assay, the DNA extension products were separated on a 15% denaturing gel (7 M urea), run in TBE buffer for 3 h at 80 W, and finally visualized by phosphorimaging (Typhoon FLA 9000).

Circular dichroism (CD) spectra were recorded on a JASCO-815 spectropolarimeter using 1-cm path length quartz cuvettes. DNA samples (strand concentration, 5 M) were dissolved in a buffer containing 70 mM potassium chloride and 20 mM potassium phosphate (pH 7) in a reaction volume of 500 L. For each experiment, an average of three scans was taken, the spectrum of the buffer was subtracted, and the data were zero-corrected at 320 nm.

The thermal denaturing of the LTR-IV G-quadruplex was monitored by UV absorption on a JASCO V-650 UV-Vis spectrophotometer. DNA concentration was 5 M. Samples contained 70 mM potassium chloride and 20 mM potassium phosphate, pH 7. Absorbance was monitored at 295 nm and zero-corrected at 320 nm, over the temperature range from 20 to 90 • C. Melting curves were baselinecorrected to compute the fraction of folded G-quadruplex over varying temperature. The melting temperature was determined as the temperature at which half the population was in the folded state.

NMR experiments were performed on 600 and 700 MHz Bruker spectrometers at 25 • C. DNA samples (strand concentration, 0.2−1.5 mM) were dissolved in a buffer containing 70 mM potassium chloride and 20 mM potassium phosphate (pH 7). Resonances for guanine residues were assigned unambiguously by using site-specific lowenrichment 15 N labeling (47) , site-specific 2 H labeling (48) and through-bond correlations at natural abundance (49) . Spectral assignments were completed by NOESY, TOCSY, ( 13 C-1 H)-HMBC and ( 13 C-1 H)-HSQC as previously described (50) . Inter-proton distances were deduced from NOESY experiments at various mixing times. All spectral analyses were performed using the SPARKY program (51) .

Structures of the LTR-IV G-quadruplex were first calculated by performing distance geometry simulated annealing using the XPLOR-NIH program (52) . The ten lowestenergy structures were then used for further refinement via molecular dynamics (MD) simulations using the AMBER 10 program (53) . Prior to MD simulation, K + ions were introduced around the structure computed in XPLOR, including internal placement between G-tetrads of the Gquadruplex. Structures were then solvated before undergoing a series of constrained minimization and simulation steps as previously described (54) . Finally, structures were refined over 1 ns of restrained MD simulations including hydrogen-bond restraints and inter-proton distance restraints. Inter-proton distances were deduced from NOESY experiments performed in H 2 O (mixing time, 300 ms) and 2 H 2 O (mixing times, 100 and 300 ms). The glycosidic dihedral restraints were based on intra-residue NOEs of H1 -H6/8 cross-peak intensities observed at the mixing time of 100 ms.

The coordinates of the LTR-IV G-quadruplex have been deposited in the Protein Data Bank under accession code 2N4Y.

The wild-type (WT) HIV-1 LTR region (corresponding to segment −381/+83 in the HIV-1 genome) was inserted into the promoterless luciferase reporter vector pGL4.10-Luc2 (Promega Italia, Italy), as previously reported (37) . The G18T mutant pGL4.10-Luc2/LTR vector was generated using QuikChange mutagenesis kit (Stratagene/Agilent Technologies) with the following primers: PrMut G18T (i) 5 -CCTGGGCGGGAC TGGGGATTGGCGAGCCCTCAGATCC-3 and PrMut G18T (ii) 5 -GGATCTGAGGGCTCGCCAATCCCCA GTCCCGCCCAGG-3 , where the mutated base is shown in boldface and underlined. Both the WT and G18T LTR sequences were confirmed by sequencing. Plasmid size was confirmed by Hind III linearization on 1% agarose gel.

Luciferase activity of the WT and G18T mutant LTRs was assessed in human embryonic kidney 293T (HEK293T) cells seeded in 12-well plates (2 × 10 5 cells/well). Cells were transfected 24 h post-seeding with pGL4.10-LTR-WT or pGL4.10-LTR-G18T (100 ng/well) using TransIT-293 transfection reagent (Mirus Bio LLC, Madison, WI, USA), according to the manufacturer's protocol. After 30 min, cells were treated with increasing concentrations (1-4 M) of BRACO-19 (ENDOTHERM, Saarbruecken, Germany) for 24 h. Luciferase activity was measured using the britelite plus Reporter Gene Assay System (PerkinElmer Inc., Milan, Italy) in a Victor X2 multilabel plate reader (PerkinElmer Inc., Milan, Italy). Cells were lysed in lysis buffer (1X PBS, 1% TRITON X-100) and protein concentration was determined by bicinchoninic acid (BCA) assay (Thermo Scientific Pierce, Monza, Italy). Luciferase signals were subsequently normalized to total protein content, according to the manufacturer's protocol (http://ita.promega.com/∼/pdf/resources/pubhub/ cellnotes/normalizing-genetic-reporter-assays/). All experiments were performed twice and in duplicate.

HEK 293T cells sustain all viral steps with the exception of virion attachment and entry as they lack cell receptors recognized by HIV-1. They can be transfected with the HIV-1 proviral genome to produce fully infectious viral particles, indicating that their cytoplasmic/nuclear protein makeup is capable of sustaining viral transcription and replication (55) .

Taq polymerase stop assay was carried out as previously described (37) . Briefly, the 5 -end labeled primer (5 -GGCAAAAAGCAGCTGCTTATATGCAG-3 ) was annealed to the templates (LTR-II+III+IV WT Taq 5 -TTTTTGGGGACTTTCCAGGGAGGCGTGGCC TGGGCGGGACTGGGGAGTGGTTTTTCTGCATA TAAGCAGCTGCTTTTTGCC-3 or LTR-II+III+IV G18T Taq 5 -TTTTTGGGGACTTTCCAGGGAGGC GTGGCCTGGGCGGGACTGGGGATTGGTTTTTCT GCATATAAGCAGCTGCTTTTTGCC-3 ) in lithium cacodylate buffer in the presence/absence of 100 mM KCl by heating to 95 • C for 5 min and gradually cooling to room temperature. Where specified, samples were incubated with BRACO-19 (62.5-250 nM). Primer extension was conducted with 2 U of AmpliTaq Gold DNA polymerase (Applied Biosystem, Carlsbad, California, USA) at 37 • C for 30 min. The marker sample was obtained by treating the elongation WT product with the sequencing protocol of Maxam et al. (56) . Reactions were stopped by ethanol precipitation, primer extension products were separated on a denaturing gel and visualized by phosphorimaging (Typhoon FLA 9000). The intensities of stop bands were quantified using ImageQuant TL software (GE Healthcare Europe, Milan, Italy).

Conservation of the G18 base involved in the LTR-IV Gquadruplex formation was evaluated by aligning 953 LTR U3 sequences of different HIV-1 subtypes including 24 subtypes A, 485 subtypes B and 119 subtypes C from the HIV Sequence Database (http://www.hiv.lanl.gov/) using Jalview (http://www.jalview.org/). The analyzed sequences belong to a broad spectrum of HIV-1 subtypes, both nonrecombinant subtypes of Group M and circulating recombinant forms.

The NMR spectrum of the LTR-IV sequence displays 12 well-resolved peaks in the imino proton region ( Figure S1 ): a major form that migrates at a rate consistent with a monomeric Gquadruplex reference and a small population of higherordered structure. Solvent exchange with 2 H 2 O reveals slow exchange rates for four imino protons ( Supplementary Figure S2 ) -corresponding to a single central G-tetrad layer. A single transition was observed in the thermal denaturing curve of LTR-IV (Supplementary Figure S3) showing a melting temperature of 50.5 • C in ∼100 mM K + . Collectively, these biophysical data suggest that LTR-IV predominantly forms a major G-quadruplex species that adopts a monomeric parallel-stranded conformation.

We set out to elucidate the G-quadruplex structure of the LTR-IV sequence. Guanine imino (H1) protons were unambiguously assigned for all guanines by carrying out 15 Nfiltered experiments of sequences containing site-specific 4% 15 N enrichment ( Figure 3A and Supplementary Figure S4 ). Unambiguous assignment of guanine H8 protons was made by site-specific 2 H labeling experiments (Supplementary Figure S4) . Assignment of selected aromatic and methyl protons of thymine residues was made by through-bond correlation experiments, using site-specific 4% 13 C, 15 N labeled samples ( Figure 3B and Supplementary Figure S5 ). Based on these assignments, the H8/H6-H1 sequence connectivity could be traced allowing for assignment of crosspeaks within NOESY spectra ( Figure 3D ).

Examining the cyclical through-space guanine H1-H8 cross peaks in NOESY spectra allowed the identification of guanine bases that make up the same G-tetrad (Figure 3C ). H1-H8 cross peaks demonstrate the formation of three guanine tetrads, G3·G7·G14·G18, G4·G8·G15·G20 and G5·G9·G16·G21, indicating a parallel-stranded Gquadruplex fold is adopted by LTR-IV ( Figure 3E ). The location of the G4·G8·G15·G20 tetrad within the center of the structure is supported by the enhanced protection of the imino protons of guanines in this tetrad during solvent exchange experiments (Supplementary Figure S2) . Guanine bases are shown to adopt an anti conformation, consistent with the intensity of their intra-residue H8-H1 cross-peaks observed in NOESY spectra.

The resulting folding topology indicates three continuous tracts of guanines, participating in G-tetrad formation, G3-G5, G7-G9 and G14-G16, in addition to a fragmented tract consisting of G18, G20 and G21. This fragmented tract results in a bulge at the T19 position. These G-tracts are connected by loops including a short 1-nt propeller loop formed by C6, a 4-nt propeller loop formed by the A10-C11-T12-G13 sequence and another short 1-nt propeller loop formed by A17. The flanking sequence C1-T2 is situated on the 5 -end of the molecule, while the T22 base is found on the 3 -end.

Structural calculation of the LTR-IV G-quadruplex was carried out based on restraints derived from NMR experiments ( Table 1 ). The ten lowest-energy structures computed were well converged ( Figure 4A and Table 1 ).

The solution structure of LTR-IV shows interesting structural motifs ( Figure 4B ). (i) The T19 bulge readily stacks with A17 of the nearby 1-nt propeller loop. This stacking interaction is supported by multiple NOEs between the sugar and aromatic protons of these residues (Figure 3D ). (ii) The 4-nt propeller loop is notably unstructured or highly dynamic, although this could potentially be due to lack of available constraints between the residues in this loop. (iii) The flanking C1 and T2 bases at the 5 -end of the molecule are located on top of the G3·G7·G14·G18 tetrad, partially capping the exposed tetrad. (iv) Similarly, T22 at the 3 -end caps the bottom G5·G9·G16·G21 tetrad. Collectively, these features give rise to a unique G-quadruplex structure containing a previously unreported loop-bulge stacking motif.

We investigated how mutations affect the structure of the LTR-IV sequence. Specifically, we examined the role of the T19 bulge and the ability of the G-quadruplex to form using other combinations of guanine bases. We synthesized a series of sequences containing base substitutions and/or base (D) Tracing the H8/6-H1' NOE sequential connectivity in NOESY spectrum (mixing time, 300 ms). Intraresidue H8/6-H1 cross-peaks are labeled with residue numbers and color coded based on G-tetrad arrangement. Missing cross-peaks are labeled with asterisks. (E) G-tetrad schematic highlighting the close proximity of H8-H1 protons used to determine guanine participation in G-tetrad formation. Folding topology of the LTR-IV sequence shows a parallel three-layered G-quadruplex conformation containing a T19 bulge. deletions ( Table 2 ) and examined resulting G-quadruplex formation in physiological K + conditions. The sequence G13T containing a G-to-T substitution at position 13 confirms that G13 does not play an important role in the Gtetrad formation. The deletion of T19 in the ΔT19 sequence tests the formation of G-quadruplex in the absence of a T19 bulge, creating a continuous GGG tract in its place. The sequence G13TΔT19 addresses these two changes concurrently. We also checked the ability of the LTR-IV sequence to utilize other guanine bases in the formation of a G-quadruplex by substituting G16 and G18 with a thymine in the G16T and G18T sequences respectively.

Mutated sequences were analyzed using NMR to ascertain their ability to form G-quadruplex and to gauge the folding similarity based on their imino proton chemical shift pattern ( Figure 5 ). The modification of G13 to T leads to small changes in the imino proton spectra of G13T but maintains the general chemical shift pattern, suggesting this guanine base is not critical to G-quadruplex formation. Similarly, the deletion of T19 in ΔT19 results in a predominant G-quadruplex conformation with a similar imino proton chemical shift pattern to that of the unmodified LTR-IV sequence, although the emergence of a small minor population is visible. This suggests the T19 bulge is also not a key factor in the formation of a parallel G-quadruplex. The introduction of both of these modifications is still tolerated in G13TΔT19, although a slightly elevated level of a minor population is observed. Alternatively, substitution of G16 or G18 with thymine disrupted the folding topology: multiple conformations are adopted in the G16T sequence, while a different conformer is observed in the G18T sequence, displaying broad imino proton peaks. In addition to changes in NMR spectra, the mutated sequences G16T and G18T demonstrate markedly different CD spectra as compared to that of the unmodified LTR-IV sequence (Supplementary Figure S6 ) suggesting these mutations are highly disrup-Nucleic Acids Research, 2016, Vol. 44, No. 13 6447 tive to the native conformer. Collectively, these data demonstrated the T19-bulge is not mandatory for the formation of a parallel G-quadruplex from the LTR-IV region of the HIV-1 LTR. In contrast, the guanines in the G14-G16 and G18-G21 stretches are required.

To assess the physiological role of the LTR-IV Gquadruplex, a G18-to-T (G18T) mutation was introduced in the full-length HIV-1 LTR promoter fused to a luciferase reporter gene. As the G18T mutation was shown to abolish the LTR-IV G-quadruplex ( Figure 5 ), we selected this sequence as a negative structural control. Both the wildtype (WT) and mutant G18T LTR-Luc plasmids were transfected into HEK 293T cells and the luciferase activity was measured. The promoter activity of the mutant G18T LTR was significantly reduced to 23% of the activity of the WT LTR ( Figure 6A ). Transfected cells were next treated with BRACO-19, a G-quadruplex ligand shown to bind and stabilize LTR-III and LTR-IV G-quadruplex structures (37) .

In the presence of the ligand, WT LTR promoter activity decreased to 68% of the untreated control at the highest tested ligand concentration (37), whereas the activity of the mu- Table 2 . LTR-IV and mutated sequences tant G18T LTR decreased to an even further extent to 33% of the untreated control ( Figure 6B) . To assess which G-quadruplex species form in the fulllength LTR promoter, a Taq polymerase stop assay was set up. The WT and mutant G18T templates were subjected to Taq polymerase processing in the absence or presence of K + and BRACO-19 ( Figure 6C and D) . The addition of the BRACO-19 ligand induced formation of LTR-IV only in the WT template and was found to stabilize LTR-III in both the WT and G18T templates. Interestingly, the LTR-III Gquadruplex was induced to a higher extent in the G18T template ( Figure 6C and D) .

Considering the dramatic effects of incorporating a single G18T base mutation on the HIV-1 promoter activity, we investigate the presence of such a mutation in about 1000 circulating viral strains available in the HIV sequence database (see 'Materials and Methods' section). We found a 99.5% degree of conservation for G18. There were five sequences observed to contain G18 mutations, four sequences contained a T mutation and one sequence an A at position G18 (Supplementary Tables S1 and 2) . Collectively, these data support the crucial role of this position in virus replication and suggest that the LTR-IV G-quadruplex could act as a modulator of activity in the HIV-1 LTR promoter.

We demonstrate here that the LTR-IV G-quadruplex adopts a well-defined parallel-stranded G-quadruplex containing a T-bulge (Figure 4) . The single-nucleotide T19 bulge of LTR-IV participates in a stacking interaction with A17 of a neighboring single-nucleotide propeller loop. While the formation and prevalence of bulged Gquadruplexes have been previously described (57) , to our knowledge, the loop-bulge interaction has not been reported so far. Although base stacking interactions between loops have previously been observed (58) (59) (60) , the loopbulge stacking and its orientation in the groove of the Gquadruplex may offer specificity in the design of a ligand specific to this structure.

It has been previously shown that the LTR-IV region is highly conserved (37) . This is particularly true for the guanine bases within this sequence, suggesting the importance of conserving the ability for LTR-IV to form a Gquadruplex structure. In this work, mutation studies of the LTR-IV sequence demonstrate that the presence of a Tbulge is not crucial to G-quadruplex formation, but can play a role in modulating the G-quadruplex stability (57) . However, at the proviral level the A17 and T19 nucleotides are within the Sp1 binding site, one of the most important transcription factors in the LTR promoter (61, 62) . Among 953 HIV-1 strains a mutation of A17 or T19 is observed in only 5 cases (1 case A17-to-G and 4 cases T19-to-G), supporting their key role in the virus life cycle. Mutation at G18, which disrupts LTR-IV G-quadruplex, is also shown to be very rare with a conservation rate of 99.5%. Collectively, the high conservation of these residues suggests that the bulge feature of the LTR-IV G-quadruplex is maintained across strains.

The LTR promoter of the proviral HIV-1 genome is crucial both for viral transcription and latency. In fact, it alone controls transcription of all nine viral genes, and repression of transcription at this level has been proposed to be involved in the switch to viral latency (63, 64) . It has been previously shown that the U3 region of the LTR can form G-quadruplexes and modulate viral transcription (44) .

Our results suggest that G-quadruplex formation in LTR-III and LTR-IV may act as a regulatory mechanism for transcription activity, with LTR-IV formation acting as a negative regulator of LTR-III. This interpretation is based on the following. (i) We have shown here that when the capacity for LTR-IV to form a G-quadruplex is lacking (by G18T mutation), the LTR promoter activity is highly silenced in cells ( Figure 6A ). This effect is likely caused by the increase in LTR-III G-quadruplex formation, in addition to the disruption of one of the three binding sites of the transcription factor Sp1. In contrast, we have previously shown that mutations that prevent formation of LTR-III lead to enhanced LTR promoter activity (37) . (ii) In the presence of BRACO-19, the G18T mutant, lacking LTR-IV quadruplex-formation capacity, leads to increased LTR-III G-quadruplex formation in vitro and decreased promoter activity in cells ( Figure 6B and D) .

We demonstrate that the LTR-IV G-quadruplex forms less readily than the LTR-III G-quadruplex, with a low population of the LTR-IV G-quadruplex forming in the full-length promoter ( Figure 6C and D) . Since the LTR-IV and LTR-III G-quadruplexes are mutually exclusive, our present data suggest that an increase of the LTR-IV G-quadruplex folding would reduce the amount of folded LTR-III. Based on our data, a disruption of the LTR-IV G-quadruplex formation reduced the LTR promoter activity, while a selective stabilisation of the LTR-IV G-quadruplex (e.g. via specific small molecules or proteins) would likely lead to increased transcriptional activity. A possible negative implication of over-active transcription could be premature cell death prior to completing virion production. Alternatively, over-active transcription could have ramifications on viral latency.

We propose the balance of LTR-III and LTR-IV Gquadruplex formation may act as a regulator of the viral promoter. The rational and selective targeting of the LTR-IV structure could lead to sharp effects on HIV-1 replication. Understanding the structures of LTR G-quadruplexes is a valuable first step in the rational design of a selective small molecule to target this region of the viral genome and modulate the transcriptional behavior of HIV.

This work reports the NMR solution structure of the LTR-IV G-quadruplex formed in the LTR promoter of proviral HIV-1 genome. Biophysical data show that LTR-IV adopts a monomeric and parallel-stranded G-quadruplex in physiological solution. In the LTR-IV G-quadruplex, a singlenucleotide bulge interacts with a nearby single-nucleotide loop in a distinctive manner not reported previously. Conservation analysis shows these residues are highly conserved in viable HIV-1 strains. We suggest the loop-bulge interaction observed in LTR-IV is a promising feature that could be exploited in the design of molecules to specifically target this structure. The LTR-IV G-quadruplex structure presented here is valuable in understanding both the biology of the HIV-1 proviral LTR and its potential as a therapeutic target.

PDB ID: 2N4Y.

Supplementary Data are available at NAR Online. 

Quadruplex DNA: sequence, topology and structure

Human telomere, oncogenic promoter and 5 -UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics

G-quadruplexes and their regulatory roles in biology

A sodium-potassium switch in the formation of four-stranded G4-DNA

Stability and kinetics of G-quadruplex structures

G-quadruplexes and metal ions

Design of a G-quadruplex topology through glycosidic bond angles

Human telomeric G-quadruplex: structures of DNA and RNA sequences

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription

Gene function correlates with potential for G4 DNA formation in the human genome

G-quadruplexes in promoters throughout the human genome

Conserved elements with potential to form polymorphic G-quadruplex structures in the first intron of human genes

The disruptive positions in human G-quadruplex motifs are less polymorphic and more conserved than their neutral counterparts

Evidence of genome-wide G4 DNA-mediated gene expression in human cancer cells

G-quadruplex-induced instability during leading-strand replication

Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

Genome-wide analyses of recombination prone regions predict role of DNA structural motif in recombination

The fragile X syndrome d(CGG) n nucleotide repeats form a stable tetrahelical structure

C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes

A G-rich element forms a G-quadruplex and regulates BACE1 mRNA alternative splicing

Neurodegenerative diseases: G-quadruplex poses quadruple threat

C9orf72 nucleotide repeat structures initiate molecular cascades of disease

G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments

Characterization of DNA G-quadruplex species forming from C9ORF72 G 4 C 2 -expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration

G-quadruplex nucleic acids and human disease

The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective

Quantitative visualization of DNA G-quadruplex structures in human cells

Detection of G-quadruplex DNA in mammalian cells

G-quadruplexes in viruses: function and potential therapeutic applications

Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment

G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation

The SARS-unique domain (SUD) of SARS coronavirus contains two macrodomains that bind G-quadruplexes

The Herpes Simplex Virus-1 genome contains multiple clusters of repeated G-quadruplex: Implications for the antiviral activity of a G-quadruplex ligand

Human papillomavirus G-quadruplexes

Formation of a unique cluster of G-quadruplex structures in the HIV-1 Nef coding region: implications for antiviral activity

A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter

Topology of a DNA G-quadruplex structure formed in the HIV-1 promoter: a potential target for anti-HIV drug development

U3 region in the HIV-1 genome adopts a G-quadruplex structure in its RNA and DNA sequence

Mechanisms of infectivity and replication of HIV-1 and implications for therapy

A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter

Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription

Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19

Synthesis, binding and antiviral properties of potent core-extended naphthalene diimides targeting the HIV-1 long terminal repeat promoter G-quadruplexes

Oligonucleotide interactions. 3. Circular dichroism studies of the conformation of deoxyoligonucleotides

A site-specific low-enrichment 15 N, 13 C isotope-labeling approach to unambiguous NMR spectral assignments in nucleic acids

An efficient and economic site-specific deuteration strategy for NMR studies of homologous oligonucleotide repeat sequences

Long-range imino proton-13 C J-couplings and the through-bond correlation of imino and non-exchangeable protons in unlabeled DNA

Investigation of unusual DNA motifs

SPARKY Version 3.115 ed. University of California

The Xplor-NIH NMR molecular structure determination package

The Amber biomolecular simulation programs

Xanthine and 8-oxoguanine in G-quadruplexes: formation of a G·G·X·O tetrad

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

Sequencing end-labeled DNA with base-specific chemical cleavages

Bulges in G-quadruplexes: broadening the definition of G-quadruplex-forming sequences

Giardia telomeric sequence d(TAGGG) 4 forms two intramolecular G-quadruplexes in K + solution: effect of loop length and sequence on the folding topology

Structure of human telomeric RNA (TERRA): Stacking of two G-quadruplex blocks in K + solution

G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold

Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G

In-vitro study of functional involvement of Sp1, Nf-Kappa-B/Rel, and Ap1 in Phorbol 12-Myristate 13-Acetate-mediated HIV-1 long terminal repeat activation

An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection

Establishment and molecular mechanisms of HIV-1 latency in T cells